Ifosfamide is one of the best-known alkylating agents. In advanced epithelial ovarian cancer, it has been tested in association with cisplatin, achieving results equal, if not better than cyclophosphamide, with acceptable toxicity. In second-line therapy, it shows remarkable activity, even in patients refractory to cisplatin already treated with cyclophosphamide, with more severe, but always manageable toxicity. In gynecological sarcomas, ifosfamide is, together with doxorubicin, the reference drug for chemotherapy.

Lissoni, A., Fei, F., Rossi, R., Fruscio, R., Villa, A., Zani, G. (2003). Ifosfamide in the treatment of malignant epithelial ovarian tumors. ONCOLOGY, 65(Suppl 2), 59-62 [10.1159/000073361].

Ifosfamide in the treatment of malignant epithelial ovarian tumors

LISSONI, ANDREA ALBERTO;FRUSCIO, ROBERT;
2003

Abstract

Ifosfamide is one of the best-known alkylating agents. In advanced epithelial ovarian cancer, it has been tested in association with cisplatin, achieving results equal, if not better than cyclophosphamide, with acceptable toxicity. In second-line therapy, it shows remarkable activity, even in patients refractory to cisplatin already treated with cyclophosphamide, with more severe, but always manageable toxicity. In gynecological sarcomas, ifosfamide is, together with doxorubicin, the reference drug for chemotherapy.
Articolo in rivista - Articolo scientifico
Carcinoma; Sarcoma; Ovarian Neoplasms; Ifosfamide; Female; Antineoplastic Agents, Alkylating; Humans
English
59
62
Lissoni, A., Fei, F., Rossi, R., Fruscio, R., Villa, A., Zani, G. (2003). Ifosfamide in the treatment of malignant epithelial ovarian tumors. ONCOLOGY, 65(Suppl 2), 59-62 [10.1159/000073361].
Lissoni, A; Fei, F; Rossi, R; Fruscio, R; Villa, A; Zani, G
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/17060
Citazioni
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 2
Social impact